These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11550942)
21. Changing frequency of interim analysis in sequential monitoring. Lan KK; DeMets DL Biometrics; 1989 Sep; 45(3):1017-20. PubMed ID: 2790114 [TBL] [Abstract][Full Text] [Related]
22. A group sequential, response-adaptive design for randomized clinical trials. Karrison TG; Huo D; Chappell R Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050 [TBL] [Abstract][Full Text] [Related]
24. Implementation of group sequential logrank tests in a maximum duration trial. Lan KK; Lachin JM Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413 [TBL] [Abstract][Full Text] [Related]
25. Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance. Li H; Wang J; Luo X; Grechko J; Jennison C Biom J; 2018 Sep; 60(5):893-902. PubMed ID: 29876964 [TBL] [Abstract][Full Text] [Related]
26. Testing secondary hypotheses following sequential clinical trials. Liu A; Tan M; Boyett JM; Xiong X Biometrics; 2000 Jun; 56(2):640-4. PubMed ID: 10877329 [TBL] [Abstract][Full Text] [Related]
28. A group sequential procedure for all-pairwise comparisons of k treatments based on the range statistic. Liu W Biometrics; 1995 Sep; 51(3):946-55. PubMed ID: 7548710 [TBL] [Abstract][Full Text] [Related]
30. Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials. Hung HM; Wang SJ; O'Neill R J Biopharm Stat; 2007; 17(6):1201-10. PubMed ID: 18027226 [TBL] [Abstract][Full Text] [Related]
31. Design and monitoring of multi-arm multi-stage clinical trials. Ghosh P; Liu L; Senchaudhuri P; Gao P; Mehta C Biometrics; 2017 Dec; 73(4):1289-1299. PubMed ID: 28346823 [TBL] [Abstract][Full Text] [Related]
32. A multiple-step selection procedure with sequential protection of preferred treatments. Chen TT; Simon R Biometrics; 1993 Sep; 49(3):753-61. PubMed ID: 8241371 [TBL] [Abstract][Full Text] [Related]
33. Gatekeeping testing via adaptive alpha allocation. Li JD; Mehrotra DV Biom J; 2008 Oct; 50(5):704-15. PubMed ID: 18932133 [TBL] [Abstract][Full Text] [Related]
34. Designing Issues in Confirmatory Adaptive Population Enrichment Trials. Wassmer G; Dragalin V J Biopharm Stat; 2015; 25(4):651-69. PubMed ID: 24905739 [TBL] [Abstract][Full Text] [Related]
35. Group sequential methods for an ordinal logistic random-effects model under misspecification. Spiessens B; Lesaffre E; Verbeke G; Kim K Biometrics; 2002 Sep; 58(3):569-75. PubMed ID: 12229991 [TBL] [Abstract][Full Text] [Related]
36. Implementing type I & type II error spending for two-sided group sequential designs. Rudser KD; Emerson SS Contemp Clin Trials; 2008 May; 29(3):351-8. PubMed ID: 17933592 [TBL] [Abstract][Full Text] [Related]
37. Data-driven analysis strategies for proportion studies in adaptive group sequential test designs. Wassmer G J Biopharm Stat; 2003 Nov; 13(4):585-603. PubMed ID: 14584710 [TBL] [Abstract][Full Text] [Related]
38. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses. Jennison C; Turnbull BW Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110 [TBL] [Abstract][Full Text] [Related]
39. Planning and monitoring of equivalence studies. Durrleman S; Simon R Biometrics; 1990 Jun; 46(2):329-36. PubMed ID: 2194579 [TBL] [Abstract][Full Text] [Related]
40. Adaptive group sequential test for clinical trials with changing patient population. Feng H; Shao J; Chow SC J Biopharm Stat; 2007; 17(6):1227-38. PubMed ID: 18027228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]